Nano-X Imaging Ltd (NNOX) - Rasio tanggungan utang jangka dawa marang modal

Nano-X Imaging Ltd. - logo grafis emiten NNOX

Nano-X Imaging Ltd. (NNOX) is a pioneer in medical imaging, creating affordable diagnostic tools for global healthcare. The Israeli management is committed to transparency in implementing digital X-ray projects, focusing on certification and sales. Growth potential is based on the deployment of cloud-based AI in developing countries. The price history on the chart below demonstrates the asset's dynamics, where the indicator stands at 0.05.

Nano-X (NNOX): Utang jangka dawa marang modal saka 04.07.2022 nganti 31.10.2026
Sampel barang Nanox

This indicator calculates the share of liabilities with a maturity of over one year relative to equity, utilizing a daily recalculation to eliminate quarterly lags. This allows for an assessment of stress resilience and default risk by analyzing the long-term debt-to-equity ratio. For Nano-X Imaging Ltd. (NNOX), this balance is critical when scaling digital radiography, confirming the ability of the Israeli centers to develop technologies through sustainable financing.

Perusahaan pesaing

Rasio utang jangka dawa marang modal ABT (Abbott Labs)|Utang jangka dawa marang modal TMO|Rasio tanggungan utang jangka dawa marang modal GE HealthCare Inc.|Utang jangka dawa marang modal MTD (Mettler-Toledo International)|Utang jangka dawa marang modal waters.com WAT|Bio-Techne - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Bruker Corp (BRKR)|Azenta Life Sciences (AZTA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal VREX|Utang jangka dawa marang ekuitas Semler Scientific, Inc.|Kewajiban jangka dawa marang modal butterflynetwork.com BFLY|Utang jangka dawa marang ekuitas Mesa Labs (MLAB)|Rasio tanggungan utang jangka dawa marang modal Quantum-Si Inc.|Quanterix Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal MASS (908 Devices Corporation)|CapsoVision Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal maxcyte.com MXCT|RPID: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Seer Inc|Rasio utang jangka dawa marang ekuitas HYPR|FONR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Daxor Corporation (DXR)|Rasio utang jangka dawa marang ekuitas Spectral AI Inc. MDAI|Utang jangka dawa marang modal VIVS (Organovo Holdings, Inc.)|Aclarion Inc (ACON) - Kewajiban jangka dawa marang modal|Akoya - Utang jangka dawa marang modal|THMO (Cesca Therapeutics) - Rasio utang jangka dawa marang modal|TLIS: Utang jangka dawa marang modal|TTOO - Rasio tanggungan utang jangka dawa marang modal